Ret Davide

Dr. Ret Davide

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Molecular Immunology
Verified
Journal Article
Open access
JPJudith Pekar
Judith Pekar
RDRet Davide
Ret Davide
Eva UntersmayerEva Untersmayer
Eva Untersmayer
For proteins to cause IgE-mediated allergic reactions, several common characteristics have to be defined, including small molecular size, solubility and stability to changing pH levels and enzymatic degradation. Nevertheless, these features are not unique for potent allergens, but are also observed in non-allergenic proteins. Due to the increasing awareness by regulatory authorities regarding the allergy pandemic, definition of characteristics unique to potent allergens would facilitate allergenicity assessment in the future. Despite major research efforts even to date the features unique for major allergens have not been elucidated so far. The route of allergen entry into the organism determines to a great extent these required characteristics. Especially orally ingested allergens are exposed to the harsh milieu of the gastrointestinal tract but might additionally be influenced by food processing. Depending on molecular properties such as disulphide bonds contributing to protein fold and formation of conformational IgE epitopes, posttranslational protein modification or protein food matrix interactions, enzymatic and thermal stability might differ between allergens. Moreover, also ligand binding influences structural stability. In the current review article, we aim at highlighting specific characteristics and molecular pattern contributing to a stabilized protein structure and overall allergenicity.

23 August 2022 in Allergy
Verified
Journal Article
Open access
JRJohanna Rohrhofer
Johanna Rohrhofer
MGMarianne Graninger
Marianne Graninger
LLLisa Lettenmaier
Lisa Lettenmaier
JSJohannes Schweighardt
Johannes Schweighardt
SGSalvatore Alessio Gentile
Salvatore Alessio Gentile
Eva UntersmayerEva Untersmayer
Eva Untersmayer

1 January 2019 in Carbohydrate Polymers
Verified
Journal Article
Closed access
RDRet Davide
Ret Davide
GSGökçe Steiner
Gökçe Steiner
SGStefano Gentilini
Stefano Gentilini
SKSimone Knaus
Simone Knaus

24 August 2019 in Allergy
Verified
Journal Article
Open access
PDF file
NSNazanin Samadi
Nazanin Samadi
MKMartina Klems
Martina Klems
DHDenise Heiden
Denise Heiden
RBRenate Bauer
Renate Bauer
CKClaudia Kitzmüller
Claudia Kitzmüller
Eva UntersmayerEva Untersmayer
Eva Untersmayer
Background: Food allergy is associated with a high personal health and economic burden. For immunomodulation toward tolerance, food compounds could be chemically modified, for example, by posttranslational protein nitration, which also occurs via diet‐derived nitrating agents in the gastrointestinal tract.Objective: We sought to analyze the effect of pretreatment with nitrated food proteins on the immune response in a mouse food allergy model and on human monocyte‐derived dendritic cells (moDCs) and PBMCs.Methods: The model allergen ovalbumin (OVA) was nitrated in different nitration degrees, and the secondary structures of proteins were determined by circular dichroism (CD). Allergy‐preventive treatment with OVA, nitrated OVA (nOVA), and maximally nitrated OVA (nOVAmax) were performed before mice were immunized with or without gastric acid‐suppression medication. Antibody levels, regulatory T‐cell (Treg) numbers, and cytokine levels were evaluated. Human moDCs or PBMCs were incubated with proteins and evaluated for expression of surface markers, cytokine production, and proliferation of Th2 as well as Tregs.Results: In contrast to OVA and nOVA, the conformation of nOVAmax was substantially changed. nOVAmax pretreated mice had decreased IgE as well as IgG1 and IgG2a levels and Treg numbers were significantly elevated, while cytokine levels remained at baseline level. nOVAmax induced a regulatory DC phenotype evidenced by a decrease of the activation marker CD86 and an increase in IL‐10 production and was associated with a higher proliferation of memory Tregs.Conclusion: Oral pretreatment with highly nitrated proteins induces a tolerogenic immune response in the food allergy model and in human immune cells.

3 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JRJohanna Rohrhofer
Johanna Rohrhofer
LHLisa Hauser
Lisa Hauser
LLLisa Lettenmaier
Lisa Lettenmaier
LLLena Lutz
Lena Lutz
LKLarissa Koidl
Larissa Koidl
Eva UntersmayerEva Untersmayer
Eva Untersmayer
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease characterized by profound fatigue, post-exertional malaise (PEM), and neurocognitive dysfunction. Immune dysregulation and gastrointestinal symptoms are commonly observed in ME/CFS patients. Despite affecting approximately 0.89% of the general population, the underlying pathophysiological mechanisms remain poorly understood. This study aimed to elucidate the relationship between immunological characteristics and intestinal barrier function in ME/CFS patients. ME/CFS patients were stratified into two groups based on their immune competence. After documentation of detailed medical records, serum and plasma samples were collected for the assessment of inflammatory immune mediators and biomarkers for intestinal barrier integrity by ELISA. We found reduced complement protein C4a levels in immunodeficient ME/CFS patients suggesting a subgroup-specific innate immune dysregulation. ME/CFS patients without immunodeficiencies exhibit a mucosal barrier leakage, as indicated by elevated levels of Lipopolysaccharide-binding protein (LBP). Stratifying ME/CFS patients based on immune competence enabled the distinction of two subgroups with different pathophysiological patterns. The study highlights the importance of emphasizing precise patient stratification in ME/CFS, particularly in the context of defining suitable treatment strategies. Given the substantial health and socioeconomic burden associated with ME/CFS, urgent attention and research efforts are needed to define causative treatment approaches.

16 November 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
EWEleonore Weidmann
Eleonore Weidmann
NSNazanin Samadi
Nazanin Samadi
MKMartina Klems
Martina Klems
DHDenise Heiden
Denise Heiden
KSKlara Seppova
Klara Seppova
Eva UntersmayerEva Untersmayer
Eva Untersmayer
Our diet is known to substantially influence the immune response not only by support of mucosal barriers but also via direct impact on immune cells. Thus, it was of great interest to compare the immunological effect of two mouse chows with substantial differences regarding micro-, macronutrient, lipid and vitamin content on the food allergic response in our previously established mouse model. As the two mouse chows of interest, we used a soy containing feed with lower fatty acid (FA) amount (soy-containing feed) and compared it to a soy free mouse chow (soy-free feed) in an established protocol of oral immunizations with Ovalbumin (OVA) under gastric acid suppression. In the animals receiving soy-containing feed, OVA-specific IgE, IgG1, IgG2a antibody levels were significantly elevated and food allergy was evidenced by a drop of body temperature after oral immunizations. In contrast, mice on soy-free diet had significantly higher levels of IL-10 and were protected from food allergy development. In conclusion, soy-containing feed was auxiliary during sensitizations, while soy-free feed supported oral tolerance development and food allergy prevention.